CiteFacts · FDA Drug Shortages · FDA source
Meperidine Hydrochloride Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Hikma Pharmaceuticals USA, Inc. | Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25) | Available | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25) | Available | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25) | Available | 08/13/2026 |
| Hospira, Inc., a Pfizer Company | Demerol, Injection, 100 mg/1 mL (NDC 0409-1180-69) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Demerol, Injection, 25 mg/1 mL (NDC 0409-1362-01) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Demerol, Injection, 50 mg/1 mL (NDC 0409-1418-01) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Demerol, Injection, 75 mg/1 mL (NDC 0409-1179-30) | Unavailable | 08/07/2026 |
Source facts
Grouped generic ingredient: Meperidine Hydrochloride Injection · 10 package records · Latest FDA row update: 08/13/2026
Therapeutic categories: Analgesia/Addiction
Dosage forms: Injection
Routes: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.